|
|||||
| トップページ >
研究紹介
> 老年病研究チーム >
運動器医学研究 > 主要文献 |
|||||
![]() |
|||||
老年病研究チーム
|
|||||
![]() |
|||||
| 1. |
Mori,S., Kishi, M., Kubo,S., Akiyoshi,T., Yamada,S.,
Miyazaki, T., Konishi,T., Maruyama,N., and Shigemoto, K.
2012. 3,4-diaminopyridine improves neuromuscular
transmission in a MuSK antibodies-induced mouse model of
myasthenia gravis. J Neuroimmunol in press. |
||||
| 2. |
Mori,S., Yamada,S., Kubo,S., Chen,J., Matsuda,S.,
Shudou,M., Maruyama,N., and Shigemoto, K. 2012. Divalent and
monovalent autoantibodies cause dysfunction of MuSK by
distinct mechanisms in a rabbit model of myasthenia gravis.
J Neuroimmunol in press. |
||||
| 3. |
Mori,S., Kubo,S., Akiyoshi,T., Yamada,S., Miyazaki,
T., Hotta,H., Desaki,J., Kishi, M., Konishi,T., Nishino,Y.,
Miyazawa, A., Maruyama,N., and Shigemoto, K. 2012.
Antibodies against Muscle-Specific Kinase Impair Both
Presynaptic and Postsynaptic Functions in a Murine Model of
Myasthenia Gravis. Am J Pathol 180:798-810. |
||||
| 4. |
Muraoka, T., Aoki, K., Iwasaki, T., Shinoda, K.,
Nakamura, A., Aburatani, H., Mori, S., Tokuyama, K., Kubota,
N., Kadowaki, T., et al. 2011. Ezetimibe decreases SREBP-1c
expression in liver and reverses hepatic insulin resistance
in mice fed a high-fat diet. Metabolism 60:617-628. |
||||
| 5. |
Shigemoto, K., Kubo, S., Mori, S., Yamada, S., Akiyoshi,
T., and Miyazaki, T. 2010. Muscle weakness and neuromuscular
junctions in aging and disease. Geriatr Gerontol Int 10
Suppl 1:S137-147. |
||||
| 6. |
Iwasawa, M., Miyazaki, T., Nagase, Y., Akiyama, T.,
Kadono, Y., Nakamura, M., Oshima, Y., Yasui, T., Matsumoto,
T., Nakamura, T., et al. 2009. The antiapoptotic protein
Bcl-xL negatively regulates the bone-resorbing activity of
osteoclasts in mice. J Clin Invest 119:3149-3159. |
||||
| 7. |
Shigemoto, K., Kubo, S., Jie, C., Hato, N., Abe, Y.,
Ueda, N., Kobayashi, N., Kameda, K., Mominoki, K., Miyazawa,
A., et al. 2008. Myasthenia gravis experimentally induced
with muscle-specific kinase. Ann N Y Acad Sci 1132:93-98. |
||||
| 8. |
Konishi, T., Ohta, K., Shigemoto, K., and Ohta, M. 2007.
Anti-alkaline phosphatase antibody positive myasthenia
gravis. J Neurol Sci 263:89-93. |
||||
| 9. |
Ohta, K., Shigemoto, K., Fujinami, A., Maruyama, N.,
Konishi, T., and Ohta, M. 2007. Clinical and experimental
features of MuSK antibody positive MG in Japan. Eur J Neurol
14:1029-1034. |
||||
| 10. |
Mori, S., and Tokuyama, K. 2007. Variation in ACE
activity affects myogenic differentiation in C2C12 cells.
Biochem Biophys Res Commun 353:369-375. |
||||
| 11. |
Mori, S., and Tokuyama, K. 2007. ACE activity affects
myogenic differentiation via mTOR signaling. Biochem Biophys
Res Commun 363:597-602. |
||||
| 12. |
Abe, Y., Takeuchi, T., Kagawa-Miki, L., Ueda, N.,
Shigemoto, K., Yasukawa, M., and Kito, K. 2007. A mitotic
kinase TOPK enhances Cdk1/cyclin B1-dependent
phosphorylation of PRC1 and promotes cytokinesis. J Mol Biol
370:231-245. |
||||
| 13. |
Shigemoto, K., Kubo, S., Maruyama, N., Hato, N., Yamada,
H., Jie, C., Kobayashi, N., Mominoki, K., Abe, Y., Ueda, N.,
et al. 2006. Induction of myasthenia by immunization against
muscle-specific kinase. J Clin Invest 116:1016-1024. |
||||
| 14. |
Miyazaki, T., Tanaka, S., Sanjay, A., and Baron, R. 2006.
The role of c-Src kinase in the regulation of osteoclast
function. Mod Rheumatol 16:68-74. |
||||
| 15. |
Ohta, K., Shigemoto, K., Kubo, S., Maruyama, N., Abe,
Y., Ueda, N., Fujinami, A., and Ohta, M. 2005. MuSK Ab
described in seropositive MG sera found to be Ab to alkaline
phosphatase. Neurology 65:1988. |
||||
| 16. |
Manktelow, E., Shigemoto, K., and Brierley, I. 2005.
Characterization of the frameshift signal of Edr, a
mammalian example of programmed -1 ribosomal frameshifting.
Nucleic Acids Res 33:1553-1563. |
||||
| 17. |
Ohta, K., Shigemoto, K., Kubo, S., Maruyama, N., Abe, Y.,
Ueda, N., and Ohta, M. 2004. MuSK antibodies in AChR
Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology
62:2132-2133. |
||||
| 18. |
Shigemoto, K., Brennan, J., Walls, E., Watson, C.J., Stott,
D., Rigby, P.W., and Reith, A.D. 2001. Identification and
characterisation of a developmentally regulated mammalian
gene that utilises -1 programmed ribosomal frameshifting.
Nucleic Acids Res 29:4079-4088. |
||||
| 19. |
Shigemoto, K., Kubo, S., Maruyama, N., Yamada, S., Obata,
K., Kikuchi, K., and Kondo, I. 2000. Identification and
characterization of 5' extension of mammalian agrin cDNA,
the exons and the promoter sequences. Biochim Biophys Acta
1494:170-174. |
||||
|
|
|||||
Copyright(C)2012 Tokyo Metropolitan Institute of Gerontology. All rights reserved. |
|||||